These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 2006138)

  • 21. Expression and function of the gamma c subunit of the IL-2, IL-4, and IL-7 receptors. Distinct interaction of gamma c in the IL-4 receptor.
    He YW; Adkins B; Furse RK; Malek TR
    J Immunol; 1995 Feb; 154(4):1596-605. PubMed ID: 7530740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A model of the complex between interleukin-4 and its receptors.
    Gustchina A; Zdanov A; Schalk-Hihi C; Wlodawer A
    Proteins; 1995 Feb; 21(2):140-8. PubMed ID: 7777489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crystal structure of human interleukin-10 at 1.6 A resolution and a model of a complex with its soluble receptor.
    Zdanov A; Schalk-Hihi C; Wlodawer A
    Protein Sci; 1996 Oct; 5(10):1955-62. PubMed ID: 8897595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Formation of an active form of the interleukin-2/15 receptor beta-chain by insertion of the intracisternal A particle in a radiation-induced mouse thymic lymphoma and its role in tumorigenesis.
    Ukai H; Ishii-Oba H; Ukai-Tadenuma M; Ogiu T; Tsuji H
    Mol Carcinog; 2003 Jun; 37(2):110-9. PubMed ID: 12766910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A turning point in the knowledge of the structure-function-activity relations of elastin].
    Alix AJ
    J Soc Biol; 2001; 195(2):181-93. PubMed ID: 11727705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure of the quaternary complex of interleukin-2 with its alpha, beta, and gammac receptors.
    Wang X; Rickert M; Garcia KC
    Science; 2005 Nov; 310(5751):1159-63. PubMed ID: 16293754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The solution structure of the F42A mutant of human interleukin 2.
    Mott HR; Baines BS; Hall RM; Cooke RM; Driscoll PC; Weir MP; Campbell ID
    J Mol Biol; 1995 Apr; 247(5):979-94. PubMed ID: 7723044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Receptor-binding conformation of the "ELR" motif of IL-8: X-ray structure of the L5C/H33C variant at 2.35 A resolution.
    Gerber N; Lowman H; Artis DR; Eigenbrot C
    Proteins; 2000 Mar; 38(4):361-7. PubMed ID: 10707023
    [TBL] [Abstract][Full Text] [Related]  

  • 29. On the peptide-antipeptide interactions in interleukin-1 receptor system.
    Kluczyk A; Cebrat M; Zbozień-Pacamaj R; Lisowski M; Stefanowicz P; Wieczorek Z; Siemion IZ
    Acta Biochim Pol; 2004; 51(1):57-66. PubMed ID: 15094825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Solution structure of interleukin-13 and insights into receptor engagement.
    Eisenmesser EZ; Horita DA; Altieri AS; Byrd RA
    J Mol Biol; 2001 Jun; 310(1):231-41. PubMed ID: 11419949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of the domain in the human interleukin-11 receptor that mediates ligand binding.
    Schleinkofer K; Dingley A; Tacken I; Federwisch M; Müller-Newen G; Heinrich PC; Vusio P; Jacques Y; Grötzinger J
    J Mol Biol; 2001 Feb; 306(2):263-74. PubMed ID: 11237599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physician Education: The Erythropoietin Receptor and Signal Transduction.
    Yoshimura A; Arai K
    Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Topology of T cell receptor-peptide/class I MHC interaction defined by charge reversal complementation and functional analysis.
    Chang HC; Smolyar A; Spoerl R; Witte T; Yao Y; Goyarts EC; Nathenson SG; Reinherz EL
    J Mol Biol; 1997 Aug; 271(2):278-93. PubMed ID: 9268659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutagenic analysis of a receptor contact site on interleukin-2: preparation of an IL-2 analog with increased potency.
    Berndt WG; Chang DZ; Smith KA; Ciardelli TL
    Biochemistry; 1994 May; 33(21):6571-7. PubMed ID: 8204593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysing lymphokine-receptor interactions of IL-1 and IL-2 by recombinant-DNA technology.
    Zurawski G
    Trends Biotechnol; 1991 Jul; 9(7):250-7. PubMed ID: 1368709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Self-association of interleukin 2 bound to its receptor.
    Kaplan D; Smith D; Huang R; Yildirim Z
    FASEB J; 1995 Aug; 9(11):1096-102. PubMed ID: 7649410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural significance of the C-terminal amphiphilic helix of interleukin-2.
    Landgraf B; Cohen FE; Smith KA; Gadski R; Ciardelli TL
    J Biol Chem; 1989 Jan; 264(2):816-22. PubMed ID: 2783421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Binding of small molecules to an adaptive protein-protein interface.
    Arkin MR; Randal M; DeLano WL; Hyde J; Luong TN; Oslob JD; Raphael DR; Taylor L; Wang J; McDowell RS; Wells JA; Braisted AC
    Proc Natl Acad Sci U S A; 2003 Feb; 100(4):1603-8. PubMed ID: 12582206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant interleukin-2 analogs. Dynamic probes for receptor structure.
    Landgraf BE; Goldstein B; Williams DP; Murphy JR; Sana TR; Smith KA; Ciardelli TL
    J Biol Chem; 1992 Sep; 267(26):18511-9. PubMed ID: 1526987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Muteins of human interleukin-1 that show enhanced bioactivities.
    Huang JJ; Newton RC; Horuk R; Matthew JB; Covington M; Pezzella K; Lin YA
    FEBS Lett; 1987 Nov; 223(2):294-8. PubMed ID: 2959567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.